Shanghai No.1 Pharmacy Co.,Ltd. (SHA:600833)

China · Delayed Price · Currency is CNY

10.69

+0.02 (0.19%)

Sep 8, 2026, 11:00 AM CST

Shanghai No.1 Pharmacy Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	2,115	2,130	1,915	1,820	2,656	1,398
Revenue Growth	4.79%	11.23%	5.26%	-31.49%	89.94%	-11.89%
Gross Profit	325.19	340.08	317.2	345.21	540.36	244.86
Operating Income	-12.68	-5.97	11.93	11.41	206.63	8.94
Net Income	69.89	57.75	163.06	89.28	143.56	49.42
Earnings Per Share	0.31	0.26	0.73	0.40	0.64	0.22
EPS Growth	48.53%	-64.38%	82.50%	-37.50%	190.91%	-29.03%

Revenue by Segment

Fiscal Year	FY 2025
Period Ending	Dec '25 Dec 31, 2025
Pharmaceutical Retail	1,268
Pharmaceutical Wholesale	802.95
Total	2,070

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	358.37	421.67	537.41	496.47	765.22	262.28
Total Debt	82.86	221.21	275.12	266.63	457.67	102.03
Net Cash (Debt)	275.5	200.46	262.29	229.83	307.55	160.26
Net Cash Growth	-6.95%	-23.57%	14.12%	-25.27%	91.91%	-51.34%
Net Cash Per Share	1.24	0.90	1.17	1.03	1.37	0.71

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	54.72	88.88	49.03	58.49	132.31	36.56
Capital Expenditures	-13.52	-15.93	-51.94	-13.88	-11.37	-12.64
Free Cash Flow	41.2	72.95	-2.91	44.61	120.94	23.92
Free Cash Flow Growth	-58.61%	-	-	-63.11%	405.61%	-66.78%

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	15.37%	15.96%	16.56%	18.97%	20.34%	17.51%
Operating Margin	-0.60%	-0.28%	0.62%	0.63%	7.78%	0.64%
Pretax Margin	4.36%	3.57%	11.29%	6.46%	7.17%	4.67%
Profit Margin	3.30%	2.71%	8.51%	4.91%	5.41%	3.53%
FCF Margin	1.95%	3.43%	-0.15%	2.45%	4.55%	1.71%

Dividends

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 8, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Dividend Per Share	0.078	0.078	0.220	0.125	0.195	0.070
Dividend Per Share Growth	-64.55%	-64.55%	76.00%	-35.90%	178.57%	-26.32%
Dividend Yield	0.73%	0.61%	1.67%	1.08%	1.82%	0.79%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 8, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	33.92	49.95	18.47	30.04	17.53	42.21
P/FCF Ratio	57.78	39.54	-	60.10	20.81	87.20
PS Ratio	1.13	1.35	1.57	1.47	0.95	1.49